期刊文献+

脂联素对心血管病变影响的研究进展 被引量:2

原文传递
导出
作者 刘蕾 李强翔
出处 《中华高血压杂志》 CAS CSCD 北大核心 2010年第9期820-822,共3页 Chinese Journal of Hypertension
基金 湖南省卫生厅(B2006-215) 湖南省博士后研究人员日常经费资助(2009年44号) 湖南省科技厅课题(2007FJ4135)
  • 相关文献

参考文献27

  • 1Arita Y, Kihara S, Ouchi N, etal. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity[J]. Biochem Biophys Res Commun, 1999,257 (1): 79-83.
  • 2Takahashi M, Arita Y, Yamagata K, et al. Genomic structure and mutations in adipose- specific gene, adiponectin[J]. Int J Obes Relat Metab Disord,2000,24(7):861-868.
  • 3Tsao TS, Tomas E, Munrey HE, etal. Role of disulfide bonds in. Acrp30/Adiponectin structure and signaling specificity[J]. J Biol Chem,2003,278(50) : 101.
  • 4Motoshima H, Wu X, Mahadev K, et al. Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL[J]. Biochem Biophys Res Commun,2004,315(2) :26-71.
  • 5Bora PS, Kaliappan S, Lyzogubov W, et al. Expression of adiponectin in choroidal tissue and inhibition of laser induced choroidal neovascularization by adiponectin[J]. Metabolism, 2007,581 (10) : 1977-1982.
  • 6Furukawa S, Fujita T, Shimabukuro M, etal. Increased oxidative stress in obesity and its impact on metabolic syndrome[J]. J Clin Invest,2004,114(12) :1752-1761.
  • 7Ouedraogo R, Xiangdong W, Shi-Qing X, et al. Adiponectin suppression of high-glucose induced reactive oxygen species in vascular endothelial cells[J]. Diabetes,2006,55(6) : 1840-1846.
  • 8Goldstein BJ, Scalia R. Adipokines and vascular disease in diabetes[J]. Curr Diab Rep,2007,7(1):25-33.
  • 9Zhu W, Cheng KK, Vanhoutte PM, etal. Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention[J]. Clin Sci (Lond), 2008,114(5) : 361-374.
  • 10Ouedraogo R, Gong Y, Berzins B, et al. Adiponectin deficiency increases leukocyte-endothetium interactions via upregulation of endothelial cell adhesion molecules in vivo[J]. J Clin Invest,2007, 117(6) : 1718-1726.

二级参考文献9

  • 1Lewicki M, Kotyla P, Jankiewicz-Ziobro K, et al. [The role of adiponectin in atherosclerosis][J]. Pol Merkur Lekarski, 2006, 20(118):494-496.
  • 2Lin SJ, Shyue SK, Hung YY, et al. Superoxide dismutase inhibits the expression of vascular cell adhesion molecule-1 and intracellular cell adhesion molecule-1 induced by tumor necrosis factor-alpha in human endothelial cells through the JNK/p38 pathways[J]. Arterioscler Thromb Vasc Biol, 2005, 25(2):334-340.
  • 3Verna L, Ganda C, Stemerman MB. In vivo low-density lipoprotein exposure induces intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 correlated with activator protein-1 expression[J]. Arterioscler Thromb Vasc Biol, 2006, 26(6):1344-1349.
  • 4Cullen JP, Morrow D, Jin Y, et al. Resveratrol, a polyphenolic phytostilbene, inhibits endothelial monocyte chemotactic protein-1 synthesis and secretion[J]. J Vasc Res, 2007, 44(1):75-84.
  • 5Li CJ, Sun HW, Zhu FL, et al. Local adiponectin treatment reduces atherosclerotic plaque size in rabbits[J]. J Endocrinol, 2007,193(1):137-145.
  • 6Chandrasekar B, Mummidi S, Mahimainathan L, et al. Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin[J]. J Biol Chem, 2006, 281(22):15099-15109.
  • 7Lee J, Jung E, Lee J, et al. Emodin inhibits TNF alpha-induced MMP-1 expression through suppression of activator protein-1(AP-1) [J]. Life Sci, 2006, 79(26):2480-2485.
  • 8Kato H, Kashiwagi H, Shiraga M, et al. Adiponectin acts as an endogenous antithrombotic factor[J]. Arterioscler Thromb Vasc Biol, 2006, 26(1):224-230.
  • 9Matsuda M, Shimomura I, Sata M, et al. Role of adiponectin in preventing vascular stenosis[J]. J Biol Chem, 2002, 277(40):37487-37491.

共引文献3

同被引文献39

  • 1林灼锋.FGF21在动脉粥样硬化发病中的作用及其机制研究[D].广州:暨南大学,2011.
  • 2高修仁.我国慢性稳定型心绞痛诊断与治疗指南解读[J].新医学,2007,38(11):704-707. 被引量:77
  • 3Nguyen T, Lau DW. The obesity epidemic and its impact on hy- pertension[J]. Can J Cardiol, 2012,28( 3 ) : 326-333.
  • 4Yvan-Charvet L, Quignard-Boulanga A. Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with ohesity[J]. Kidney Int,2011,79(2) :162-168.
  • 5Lamacchia O, Nicastro V, Camarchio D, et al. Para and perirenal fat thickness is an independent predictor of chronic kidney dis- ease, increased renal resistance index and hyperuricaemia in type-2 diabetic patients[J]. Nephrol Diatl Transplant, 2011,26 ( 3 ) : 892 -898.
  • 6Ma LJ, Nakamura S, Aldigier JC, et al. Regression of glomeru- loselerosis with high-dose angiotensin inhibition is linked to de- creased plasminogen activator inhibitor-1[J]. J Am Soe Nephrol, 2005,16(4) :966-976.
  • 7Tanaka R, Kon V, Yoshioka T, et al. Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms[J]. Kidney Int, 1994,45(2):537 -553.
  • 8Barandier C, Montani JP, Yang Z. Mature adipocytes and perivascular adipose tissue stimulate vascular smooth muscle cell proliferation: effects of aging and obesity[J]. Am J Physiol Heart Circ Physiol. 2005,289(5) :H1807-H813.
  • 9Boothby M, McGee KC, Tomlinson JW, et al. Adipocyte differ entialion, mitoehondrial gene expression and fat distribution:differences between zidovudine and tenofovir after 6 months[J]. Antivir Ther,2009,14(8) : 1089-1100.
  • 10Wolf G, Chen S, Han DC, et al. Leptin and renal disease[J]. Am J Kidney Dis,2002,39(1) : 1-11.

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部